Translation initiation proteins, ubiquitin proteasome system related proteins, and 14-3-3 proteins as response proteins in FL cells exposed to anti-benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide

Proteomics

Volumn 8, Issue 17, 2008, Pages 3450-3468

  Shen, Wenyan ^a,b   Liu, Hui ^a   Yu, Yingnian ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Jiaxing Second Hospital   (China)

Author keywords

2 DE; Anti benzo a pyrene 7,8 dihydrodiol 9,10 epoxide; Differentially expressed proteomic profile; MALDI TOF MS

Indexed keywords

BENZO[A]PYRENE 7,8 DIHYDRODIOL 9,10 OXIDE; BENZO[A]PYRENE DERIVATIVE; BIOLOGICAL MARKER; CARCINOGEN; POLYCYCLIC AROMATIC HYDROCARBON; PROTEASOME; PROTEIN 14 3 3; UBIQUITIN;

AMINO ACID SEQUENCE; AMNION CELL; ARTICLE; CELL TRANSFORMATION; CHEMICAL CARCINOGENESIS; COMBUSTION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EPITHELIUM CELL; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; POLLUTANT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TOXICOKINETICS; TRANSLATION INITIATION; TWO DIMENSIONAL ELECTROPHORESIS; UNINDEXED SEQUENCE;

14-3-3 PROTEINS; 7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; AMNION; CARCINOGENS; CELL LINE; CYTOSKELETAL PROTEINS; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPITHELIAL CELLS; EUKARYOTIC INITIATION FACTOR-3; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; RIBONUCLEOPROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UBIQUITIN THIOLESTERASE; UP-REGULATION;

EUKARYOTA;

EID: 52649178355     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800085     Document Type: Article

References (54)

1. Phillips, D. H., Fifty years of benzo(a)pyrene. Nature 1983, 303, 468-472.
2. Bartsch, H., Hietanen, E., The role of individual susceptibility in cancer burden related to environmental exposure. Environ. Health Perspect. 1996, 104, 569-577.
3. Conney, A. H., Chang, R. L., Jerina, D. M., Wei, S. J., Studies on the metabolism of benzo[a)pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev. 1994, 26, 125-163.
4. Shimada, T., Gillam, E. M., Oda, Y., Tsumura, F. et al., Metabolism of benzo[a]pyrene to trans-7,8-dihydroxy-7, 8-dihydrobenzo[a]pyrene by recombinant human cytochrome P450 1B1 and purified liver epoxide hydrolase. Chem. Res. Toxicol. 1999, 12, 623-629.
5. Boysen, G., Hecht, S. S., Analysis of DNA and protein adducts of benzo[a]pyrene in human tissues using structure-specific methods. Mutat. Res. 2003, 543, 17-30.
6. van Steeg, H., The role of nucleotide excision repair and loss of p53 in mutagenesis and carcinogenesis. Toxicol. Lett. 2001, 120, 209-219.
7. Wani, M. A., El-Mahdy, M. A., Hamada, F. M., Wani, G. et al., Efficient repair of bulky anti-BPDE DNA adducts from non-transcribed DNA strand requires functional p53 but not p21(waf1/cip1) and pRb. Mutat. Res. 2002, 505, 13-25.
8. Zhao, B., Wang, J., Geacintov, N. E., Wang, Z., Poleta, Polzeta and Revl together are required for G to T transversion mutations induced by the (+)- and (-)-trans-anti-BPDE-N2-dG DNA adducts in yeast cells. Nucleic Acids Res. 2006, 34, 417-425.
9. Zhang, Y., Wu, X., Guo, D., Rechkoblit, O. et al., Two-step error-prone bypass of the ( + )- and (-)-trans-anti-BPDE-N2-dG adducts by human DNA polymerases eta and kappa. Mutat. Res. 2002, 510, 23-35.
10. Shackelford, R. E., Kaufmann, W. K., Paules, R. S., Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ. Health Perspect. 1999, 101, 5-24.
11. Jeffy, B. D., Chen, E. J., Gudas, J. M., Romagnolo, D. F., Disruption of cell cycle kinetics by benzo[a]pyrene: Inverse expression patterns of BRCA-1 and p53 in MCF-7 cells arrested in S and G2. Neoplasia 2000, 2, 460-470.
12. Akerman, G. S., Rosenzweig, B. A., Domon, O. E., McGarrity, L. J. et al., Gene expression profiles and genetic damage in benzo(a)pyrene diol epoxide-exposed TK6 cells. Mutat. Res. 2004, 549, 43-64.
13. Yu, Z., Ford, B. N., Glickman, B. W., Identification of genes responsive to BPDE treatment in HeLa cells using cDNA expression assays. Environ. Mol. Mutagen. 2000, 36, 201-205.
14. Olden, K., Wilson, S., Environmental health and genomics: Visions and implications. Nat. Rev. Genet. 2000, 1, 149-153.
15. Luo, W., Fan, W., Xie, H., Jing, L. et al., Phenotypic anchoring of global gene expression profiles induced by N-hydroxy-4-acetylaminobiphenyl and benzo[a]pyrene diol epoxide reveals correlations between expression profiles and mechanism of toxicity. Chem. Res. Toxicol. 2005, 18, 619-629.
16. Nesatyy, V. J., Suter, M. J., Proteomics for the analysis of environmental stress responses in organisms. Environ. Sci. Technol. 2007, 41, 6891-6900.
17. Oh, S., Im, H., Oh, E., Lee, J. et al., Effects of benzo(a)pyrene on protein expression in Jurkat T-cells. Proteomics 2004, 4, 3514-3526.
18. Gao, Z., Jin, J., Yang, J., Yu, Y., Zinc finger proteins and other transcription regulators as response proteins in benzo[a]pyrene exposed cells. Mutat. Res. 2004, 550, 11-24.
19. Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
20. Dong, Z., Zhang, J. T., Initiation factor elF3 and regulation of mRNA translation, cell growth, and cancer. Crit. Rev. Oncol. Hematol. 2006, 59, 169-180.
21. Holz, M. K., Ballif, B. A., Gygi, S. P., Blenis, J., mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 2005, 123, 569-580.
22. Singh, C. R., Udagawa, T., Lee, B., Wassink, S. et al., Change in nutritional status modulates the abundance of critical preinitiation intermediate complexes during translation initiation in vivo. J. Mol. Biol. 2007, 370, 315-330.
23. Joseph, P., Lei, Y. X., Whong, W. Z., Ong, T. M., Molecular cloning and functional analysis of a novel cadmium-responsive proto-oncogene. Cancer Res. 2002, 62, 703-707.
24. Joseph, P., Lei, Y. X., Ong, T. M., Up-regulation of expression of translation factors - a novel molecular mechanism for cadmium carcinogenesis. Mol. Cell. Biochem. 2004, 255, 93-101.
25. Lei, Y. X., Joseph, P., Ong, T. M., Antisense inhibition of translation initiation factor 3 reverses its oncogenic potential. Teratog. Carcinog. Mutagen. 2002, 22, 403-409.
26. Choy, L., Derynck, R., The type II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response. J. Biol. Chem. 1998, 273, 31455-31462.
27. Nupponen, N. N., Porkka, K., Kakkola, L., Tanner, M. et al., Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer. Am. J. Pathol. 1999, 154, 1777-1783.
28. Okamoto, H., Yasui, K., Zhao, C., Arii, S., Inazawa, J., PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas. Hepatology 2003, 38, 1242-1249.
29. Shen, X., Yang, Y., Liu, W., Sun, M. et al., Identification of the p28 subunit of eukaryotic initiation factor 3(elF3k) as a new interaction partner of cyclin D3. FEBS Lett. 2004, 573, 139-146.
30. Sun, Y., Li, X., Wu, B., Sun, P., Rao, Z., Crystallization and preliminary crystallographic analysis of human eukaryotic translation initiation factor 5A (elF-5A). Protein Pept. Lett. 2005, 12, 713-715.
31. Li, A. L., Li, H. Y., Jin, B. F., Ye, Q. N. et al., A novel elF5A complex functions as a regulator of p53 and p53-dependent apoptosis. J. Biol. Chem. 2004, 279, 49251-49258.
32. Nandi, D., Tahiliani, P., Kumar, A., Chandu, D., The ubiquitin-proteasome system. J. Biosci. 2006, 31, 137-155.
33. Larsen, C. N., Krantz, B. A., Wilkinson, K. D., Substrate specificity of deubiquitinating enzymes: Ubiquitin C-terminal hydrolases. Biochemistry 1998, 37, 3358-3368.
34. Nam, M. J., Madoz-Gurpide, J., Wang, H., Lescure, P. et al., Molecular profiling of the immune response in colon cancer using protein microarrays: Occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics 2003, 3, 2108-2115.
35. Miyoshi, Y., Nakayama, S., Torikoshi, Y., Tanaka, S. et al., High expression of ubiquitin carboy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Cancer Sci. 2006, 97, 523-529.
36. Rolen, U., Kobzeva, V., Gasparjan, N., Ovaa, H. et al., Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines. Mol. Carcinog. 2006, 45, 260-269.
37. Kwon, J., The new function of two ubiquitin C-terminal hydrolase isozymes as reciprocal modulators of germ cell apoptosis. Exp. Anim. 2007, 56, 71-77.
38. Sano, Y., Furuta, A., Setsuie, R., Kikuchi, H. et al., Photoreceptor cell apoptosis in the retinal degeneration of Uchl3-deficient mice. Am. J. Pathol. 2006, 169, 132-141.
39. Baek, K. H., Cytokine-regulated protein degradation by the ubiquitination system. Curr. Protein Pept. Sci. 2006, 7, 171-177.
40. Adjaye, J., Herwig, R., Brink, T. C., Herrmann, D. et al., Conserved molecular portraits of bovine and human blastocysts as a consequence of the transition from maternal to embryonic control of gene expression. Physiol. Genomics 2007, 31, 315-317.
41. Cui, F., Wang, Y., Wang, J., Wei, K. et al., The up-regulation of proteasome subunits and lysosomal proteases in hepatocellular carcinomas of the HBx gene knockin transgenic mice. Proteomics 2006, 6, 498-504.
42. Kannangai, R., Vivekanandan, P., Martinez-Murillo, F., Choti, M., Torbenson, M., Fibrolamellar carcinomas show over-expression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways. Hum. Pathol. 2007, 38, 639-644.
43. Razeghi, P., Baskin, K. K., Sharma, S., Young, M. E. et al., Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart. Biochem. Biophys. Res. Commun. 2006, 342, 361-364.
44. Lin, Y., Martin, J., Gruendler, C., Farley, J. et al., A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs). BMC Cell Biol. 2002, 3, 15.
45. Wiseman, S. B., Vijayan, M. M., Aryl hydrocarbon receptor signaling in rainbow trout hepatocytes: Role of hsp90 and the proteasome. Comp. Biochem. Physiol. C: Toxicol. Pharmacol. 2007, 146, 484-491.
46. Dalai, S. N., Yaffe, M. B., DeCaprio, J. A., 14-3-3 family members act coordinately to regulate mitotic progression. Cell Cycle (Georgetown, Tex.) 2004, 3, 672-677.
47. Qi, W., Martinez, J. D., Reduction of 14-3-3 proteins correlates with increased sensitivity to killing of human lung cancer cells by ionizing radiation. Radiat. Res. 2003, 160, 217-223.
48. Bomsztyk, K., Denisenko, O., Ostrowski, J., hnRNP K: One protein multiple processes. Bioessays 2004, 26, 629-638.
49. Moumen, A., Masterson, P., O'Connor, M. J., Jackson, S. P., hnRNP K: An HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Cell 2005, 123, 1065-1078.
50. Peters, A. H., O'Carroll, D., Scherthan, H., Mechtler, K. et al., Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell 2001, 107, 323-337.
51. Kim, K. C., Geng, L., Huang, S., Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res. 2003, 63, 7619-7623.
52. Gomez-Mendikute, A., Etxeberria, A., Olabarrieta, I., Cajaraville, M. P., Oxygen radicals production and actin filament disruption in bivalve haemocytes treated with benzo(a)pyrene. Mar. Environ. Res. 2002, 54, 431-436.
53. Wittmann-Liebold, B., Graack, H. R., Pohl, T., Two-dimensional gel electrophoresis as tool for proteomics studies in combination with protein identification by mass spectrometry. Proteomics 2006, 6, 4688-4703.
54. Delom, F., Chevet, E., Phosphoprotein analysis: From proteins to proteomes. Proteome Sci. 2006, 4, 15.